Clinical Trials Logo

HCV Recurrence clinical trials

View clinical trials related to HCV Recurrence.

Filter by:
  • None
  • Page 1

NCT ID: NCT01944527 Active, not recruiting - Clinical trials for Liver Transplantation

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

ANRSCO23CUPILT
Start date: October 2013
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the efficacy, safety and tolerability of direct-acting antivirals therapy in liver transplanted patients who experienced HCV recurrence. This cohort is multicentric with constitution of biobank (plasma, serum) and the prospective collect of biological and clinical data's in the liver transplanted patients with recurrent HCV infection and treated with direct-acting anti-HCV agents.